Do analysts prefer HYPD or CNTN?

Hyperion DeFi currently has a consensus target price of $7.20, suggesting a potential upside of 118.18%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, analysts clearly believe Hyperion DeFi is more favorable than Hillstream Biopharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 2 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Hillstream Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend HYPD or TONX?

Hyperion DeFi currently has a consensus target price of $7.20, suggesting a potential upside of 118.18%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, equities analysts plainly believe Hyperion DeFi is more favorable than Verb Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 2 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Verb Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NAKA or HYPD more profitable?

Hyperion DeFi has a net margin of 416.56% compared to KindlyMD's net margin of -1,067.93%. Hyperion DeFi's return on equity of -11.62% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% Hyperion DeFi 416.56% -11.62% -9.96%

Which has better earnings & valuation, HSDT or HYPD?

Solana has higher revenue and earnings than Hyperion DeFi. Hyperion DeFi is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solana $6.02M 22.50 -$40.89M -$30.32 N/A Hyperion DeFi $810K 63.31 -$45.31M -$6.53 N/A

Is HSDT or HYPD more profitable?

Hyperion DeFi has a net margin of 416.56% compared to Solana's net margin of -1,302.78%. Hyperion DeFi's return on equity of -11.62% beat Solana's return on equity. Company Net Margins Return on Equity Return on Assets Solana -1,302.78% -41.86% -18.53% Hyperion DeFi 416.56% -11.62% -9.96%

Hyperion DeFi (HYPD) Competitors

$3.30 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Compare

HYPD vs. CNTN, TONX, DFDV, NAKA, and HSDT

Should you buy Hyperion DeFi stock or one of its competitors? Hyperion DeFi's main competitors and comparable companies include Hillstream Biopharma (CNTN), Verb Technology (TONX), DeFi Development (DFDV), KindlyMD (NAKA), and Solana (HSDT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does Hyperion DeFi compare to Hillstream Biopharma?

Hyperion DeFi (NASDAQ:HYPD) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Hyperion DeFi has a net margin of 416.56% compared to Hillstream Biopharma's net margin of 0.00%. Hyperion DeFi's return on equity of -11.62% beat Hillstream Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
Hillstream Biopharma	N/A	-20.06%	-15.90%

Hillstream Biopharma has lower revenue, but higher earnings than Hyperion DeFi. Hillstream Biopharma is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	63.31	-$45.31M	-$6.53	N/A
Hillstream Biopharma	N/A	N/A	-$35.92M	-$0.50	N/A

Hyperion DeFi has a beta of 2.53, suggesting that its share price is 153% more volatile than the broader market. Comparatively, Hillstream Biopharma has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market.

Hyperion DeFi currently has a consensus target price of $7.20, suggesting a potential upside of 118.18%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, analysts clearly believe Hyperion DeFi is more favorable than Hillstream Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

25.8% of Hyperion DeFi shares are owned by institutional investors. Comparatively, 1.2% of Hillstream Biopharma shares are owned by institutional investors. 7.5% of Hyperion DeFi shares are owned by insiders. Comparatively, 3.3% of Hillstream Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Hyperion DeFi's average media sentiment score of 0.00 equaled Hillstream Biopharma'saverage media sentiment score.

Company	Overall Sentiment
Hyperion DeFi	Neutral
Hillstream Biopharma	Neutral

Summary

Hyperion DeFi beats Hillstream Biopharma on 11 of the 13 factors compared between the two stocks.

How does Hyperion DeFi compare to Verb Technology?

Hyperion DeFi (NASDAQ:HYPD) and Verb Technology (NASDAQ:TONX) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

25.8% of Hyperion DeFi shares are held by institutional investors. Comparatively, 7.2% of Verb Technology shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by company insiders. Comparatively, 21.4% of Verb Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Hyperion DeFi has a beta of 2.53, meaning that its share price is 153% more volatile than the broader market. Comparatively, Verb Technology has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Hyperion DeFi has a net margin of 416.56% compared to Verb Technology's net margin of -497.15%. Hyperion DeFi's return on equity of -11.62% beat Verb Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
Verb Technology	-497.15%	-60.82%	-59.56%

In the previous week, Verb Technology had 1 more articles in the media than Hyperion DeFi. MarketBeat recorded 1 mentions for Verb Technology and 0 mentions for Hyperion DeFi. Hyperion DeFi's average media sentiment score of 0.00 equaled Verb Technology'saverage media sentiment score.

Company	Overall Sentiment
Hyperion DeFi	Neutral
Verb Technology	Neutral

Hyperion DeFi currently has a consensus target price of $7.20, suggesting a potential upside of 118.18%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, equities analysts plainly believe Hyperion DeFi is more favorable than Verb Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Verb Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hyperion DeFi has higher earnings, but lower revenue than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	63.31	-$45.31M	-$6.53	N/A
Verb Technology	$12.78M	14.31	-$148.48M	-$1.04	N/A

Summary

Hyperion DeFi beats Verb Technology on 11 of the 15 factors compared between the two stocks.

How does Hyperion DeFi compare to DeFi Development?

Hyperion DeFi (NASDAQ:HYPD) and DeFi Development (NASDAQ:DFDV) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Hyperion DeFi has a net margin of 416.56% compared to DeFi Development's net margin of -1,319.45%. DeFi Development's return on equity of 17.97% beat Hyperion DeFi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
DeFi Development	-1,319.45%	17.97%	5.02%

Hyperion DeFi has a beta of 2.53, indicating that its share price is 153% more volatile than the broader market. Comparatively, DeFi Development has a beta of -3.75, indicating that its share price is 475% less volatile than the broader market.

In the previous week, DeFi Development had 5 more articles in the media than Hyperion DeFi. MarketBeat recorded 5 mentions for DeFi Development and 0 mentions for Hyperion DeFi. DeFi Development's average media sentiment score of 0.13 beat Hyperion DeFi's score of 0.00 indicating that DeFi Development is being referred to more favorably in the news media.

Company	Overall Sentiment
Hyperion DeFi	Neutral
DeFi Development	Neutral

Hyperion DeFi presently has a consensus target price of $7.20, suggesting a potential upside of 118.18%. DeFi Development has a consensus target price of $4.70, suggesting a potential downside of 19.93%. Given Hyperion DeFi's higher probable upside, equities analysts clearly believe Hyperion DeFi is more favorable than DeFi Development.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
DeFi Development	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Hyperion DeFi has higher earnings, but lower revenue than DeFi Development. DeFi Development is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	63.31	-$45.31M	-$6.53	N/A
DeFi Development	$11.39M	15.98	-$73.79M	-$9.98	N/A

25.8% of Hyperion DeFi shares are held by institutional investors. Comparatively, 0.5% of DeFi Development shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by company insiders. Comparatively, 23.6% of DeFi Development shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Hyperion DeFi beats DeFi Development on 9 of the 16 factors compared between the two stocks.

How does Hyperion DeFi compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and Hyperion DeFi (NASDAQ:HYPD) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

In the previous week, KindlyMD had 2 more articles in the media than Hyperion DeFi. MarketBeat recorded 2 mentions for KindlyMD and 0 mentions for Hyperion DeFi. KindlyMD's average media sentiment score of 0.87 beat Hyperion DeFi's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
Hyperion DeFi	Neutral

KindlyMD has a beta of 15.99, meaning that its stock price is 1,499% more volatile than the broader market. Comparatively, Hyperion DeFi has a beta of 2.53, meaning that its stock price is 153% more volatile than the broader market.

Hyperion DeFi has a net margin of 416.56% compared to KindlyMD's net margin of -1,067.93%. Hyperion DeFi's return on equity of -11.62% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Hyperion DeFi	416.56%	-11.62%	-9.96%

Hyperion DeFi has lower revenue, but higher earnings than KindlyMD. Hyperion DeFi is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	79.96	-$52.23M	-$35.85	N/A
Hyperion DeFi	$810K	63.31	-$45.31M	-$6.53	N/A

25.8% of Hyperion DeFi shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by company insiders. Comparatively, 7.5% of Hyperion DeFi shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

KindlyMD currently has a consensus price target of $19.33, indicating a potential upside of 137.80%. Hyperion DeFi has a consensus price target of $7.20, indicating a potential upside of 118.18%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Hyperion DeFi.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Hyperion DeFi	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

KindlyMD beats Hyperion DeFi on 10 of the 16 factors compared between the two stocks.

How does Hyperion DeFi compare to Solana?

Solana (NASDAQ:HSDT) and Hyperion DeFi (NASDAQ:HYPD) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

Hyperion DeFi has a net margin of 416.56% compared to Solana's net margin of -1,302.78%. Hyperion DeFi's return on equity of -11.62% beat Solana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solana	-1,302.78%	-41.86%	-18.53%
Hyperion DeFi	416.56%	-11.62%	-9.96%

Solana has higher revenue and earnings than Hyperion DeFi. Hyperion DeFi is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solana	$6.02M	22.50	-$40.89M	-$30.32	N/A
Hyperion DeFi	$810K	63.31	-$45.31M	-$6.53	N/A

In the previous week, Solana had 3 more articles in the media than Hyperion DeFi. MarketBeat recorded 3 mentions for Solana and 0 mentions for Hyperion DeFi. Solana's average media sentiment score of 0.81 beat Hyperion DeFi's score of 0.00 indicating that Solana is being referred to more favorably in the media.

Company	Overall Sentiment
Solana	Positive
Hyperion DeFi	Neutral

Solana has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market. Comparatively, Hyperion DeFi has a beta of 2.53, suggesting that its share price is 153% more volatile than the broader market.

Solana currently has a consensus target price of $3.75, indicating a potential upside of 67.41%. Hyperion DeFi has a consensus target price of $7.20, indicating a potential upside of 118.18%. Given Hyperion DeFi's higher possible upside, analysts clearly believe Hyperion DeFi is more favorable than Solana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solana	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Hyperion DeFi	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

18.6% of Solana shares are owned by institutional investors. Comparatively, 25.8% of Hyperion DeFi shares are owned by institutional investors. 14.4% of Solana shares are owned by company insiders. Comparatively, 7.5% of Hyperion DeFi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Solana and Hyperion DeFi tied by winning 8 of the 16 factors compared between the two stocks.

Get Hyperion DeFi News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HYPD vs. The Competition

Export

Metric	Hyperion DeFi	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$51.28M	$27.39B	$14.28B	$12.92B
Dividend Yield	N/A	6.05%	5.88%	8.90%
P/E Ratio	-0.51	19.55	26.17	25.42
Price / Sales	63.31	421.84	523.77	94.88
Price / Cash	N/A	166.20	39.59	52.28
Price / Book	0.50	3.18	2.13	6.17
Net Income	-$45.31M	$1.10B	$1.32B	$349.50M
7 Day Performance	1.23%	0.78%	0.24%	-0.05%
1 Month Performance	20.88%	11.64%	1.56%	0.80%
1 Year Performance	-46.25%	0.51%	12.05%	15.62%

Hyperion DeFi Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HYPD Hyperion DeFi	2.1853 of 5 stars	$3.30 flat	$7.20 +118.2%	-43.9%	$51.28M	$810K	N/A	40	Analyst Upgrade
CNTN Hillstream Biopharma	0.2477 of 5 stars	$2.27 -0.4%	N/A	N/A	$180.87M	N/A	N/A	2
TONX Verb Technology	0.9403 of 5 stars	$3.13 -7.9%	N/A	N/A	$172.37M	$12.78M	N/A	170	Positive News Gap Up High Trading Volume
DFDV DeFi Development	1.6798 of 5 stars	$5.06 -5.9%	$4.70 -7.1%	-63.1%	$156.86M	$11.39M	N/A	N/A	Gap Down
NAKA KindlyMD	3.6131 of 5 stars	$7.09 -5.3%	$22.33 +215.0%	-95.1%	$126.91M	$1.82M	N/A	N/A	Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HYPD) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hyperion DeFi (HYPD) Competitors

HYPD vs. CNTN, TONX, DFDV, NAKA, and HSDT

How does Hyperion DeFi compare to Hillstream Biopharma?

Summary

How does Hyperion DeFi compare to Verb Technology?

Summary

How does Hyperion DeFi compare to DeFi Development?

Summary

How does Hyperion DeFi compare to KindlyMD?

Summary

How does Hyperion DeFi compare to Solana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD vs. The Competition

Hyperion DeFi Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hyperion DeFi (HYPD) Competitors

HYPD vs. CNTN, TONX, DFDV, NAKA, and HSDT

How does Hyperion DeFi compare to Hillstream Biopharma?

Is HYPD or CNTN more profitable?

Which has stronger valuation and earnings, HYPD or CNTN?

Which has more risk and volatility, HYPD or CNTN?

Do analysts prefer HYPD or CNTN?

Do insiders & institutionals have more ownership in HYPD or CNTN?

Does the media refer more to HYPD or CNTN?

Summary

How does Hyperion DeFi compare to Verb Technology?

Do institutionals and insiders have more ownership in HYPD or TONX?

Which has more volatility & risk, HYPD or TONX?

Is HYPD or TONX more profitable?

Does the media favor HYPD or TONX?

Do analysts recommend HYPD or TONX?

Which has stronger valuation and earnings, HYPD or TONX?

Summary

How does Hyperion DeFi compare to DeFi Development?

Is HYPD or DFDV more profitable?

Which has more risk & volatility, HYPD or DFDV?

Does the media prefer HYPD or DFDV?

Do analysts prefer HYPD or DFDV?

Which has preferable earnings and valuation, HYPD or DFDV?

Do insiders & institutionals hold more shares of HYPD or DFDV?

Summary

How does Hyperion DeFi compare to KindlyMD?

Does the media favor NAKA or HYPD?

Which has more risk and volatility, NAKA or HYPD?

Is NAKA or HYPD more profitable?

Which has better earnings and valuation, NAKA or HYPD?

Do institutionals & insiders have more ownership in NAKA or HYPD?

Do analysts rate NAKA or HYPD?

Summary

How does Hyperion DeFi compare to Solana?

Is HSDT or HYPD more profitable?

Which has better earnings & valuation, HSDT or HYPD?

Does the media prefer HSDT or HYPD?

Which has more volatility & risk, HSDT or HYPD?

Do analysts recommend HSDT or HYPD?

Do institutionals & insiders believe in HSDT or HYPD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD vs. The Competition

Hyperion DeFi Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools